GlobeNewswire Inc.··Not SpecifiedNeurAxis to Report Q1 2026 Results as Neuromodulation Startup Eyes Commercial Traction
NeurAxis will report Q1 2026 financial results on May 12, 2026, as the neuromodulation company continues commercializing its FDA-cleared IB-Stim technology.
NRXSmedical technologyQ1 2026 earnings